Bristol-Myers Squibb to Hold Investor Teleconference to Discuss CMSTO Highlights
October 13 2014 - 9:00AM
Business Wire
Bristol-Myers Squibb Company (NYSE:BMY) will host a
teleconference on Friday, October 31, 2014, at 2:30 p.m. EDT (1:30
p.m. CDT) to review data presented at the Chicago Multidisciplinary
Symposium on Thoracic Oncology (CMSTO) in Chicago. Company
executives will provide an overview of data presented at the
meeting, with a focus on the company’s immuno-oncology portfolio,
and address inquiries from investors and analysts.
Investors and the general public are invited to listen to a live
webcast of the call at: http://investor.bms.com or by dialing
647-788-4901, conference code: 19907013. Materials related to the
call will be available at the same website prior to the call. A
replay of the call will be available beginning at 3:30 p.m. EDT on
October 31, 2014 through 1:59 EST on November 11, 2014. The replay
can be accessed at http://investor.bms.com or by dialing
404-537-3406, confirmation code: 19907013.
About Bristol-Myers
Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose
mission is to discover, develop and deliver innovative medicines
that help patients prevail over serious diseases. For more
information, please visit www.bms.com or follow us on Twitter at
http://twitter.com/bmsnews.
Bristol-Myers Squibb CompanyMedia:Laura Hortas,
609-252-4587laura.hortas@bms.comorInvestors:John Elicker,
609-252-4611john.elicker@bms.comorRanya Dajani,
609-252-5330ranya.dajani@bms.comorRyan Asay,
609-252-5020ryan.asay@bms.com
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Apr 2023 to Apr 2024